STENOCARE products are being used in clinical trials at Rigshospitalet Multiple Sclerosis Center
The Danish Programme for medical cannabis has objectives to both enable patients to be treated with cannabis, and to learn about the effects of the treatment via clinical trials. According to the Danish Ministry of Health more than 1400 patients have been treated with medical cannabis during the last 14 mths – which is a higher number than expected by the Ministry.Thomas Skovlund Schnegelsberg, CEO STENOCARE comments: “The number of patients has grown months after months – as physicians prescribe medical cannabis as part of the treatment of pain, sclerosis and other illnesses. Denmark